We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.68%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$11.1B
AUM Growth
+$351M
(+3.3%)
Cap. Flow
-$94.6M
Cap. Flow
% of AUM
-0.85%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
2,523
New
200
Increased
627
Reduced
680
Closed
198
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$22.5M |
| 2 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$19.3M |
| 3 |
Cummins
CMI
|
+$18.1M |
| 4 |
Synaptics
SYNA
|
+$17.8M |
| 5 |
Radian Group
RDN
|
+$17.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$33.3M |
| 2 |
PL
PROTECTIVE LIFE CORP
PL
|
+$27.2M |
| 3 |
3M
MMM
|
+$19.1M |
| 4 |
AGN
Allergan Inc
AGN
|
+$15.5M |
| 5 |
MEAS
MEASUREMENT SPECIALTIES INC
MEAS
|
+$14.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.49% |
| 2 | Industrials | 13.16% |
| 3 | Healthcare | 12.87% |
| 4 | Financials | 10.93% |
| 5 | Energy | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Dentsply Sirona
XRAY
$2.59B
| $203K | ﹤0.01% |
4,293
-7
| -0.2% | -$326 |
|
|
CBM
1102
DELISTED
Cambrex Corporation
CBM
| $203K | ﹤0.01% |
9,823
+9,320
| +1,853% | +$189K |
|
1103
Boston Properties
BXP
$11B
| $202K | ﹤0.01% |
1,720
| – | – |
|
1104
iShare MSCI Eurozone ETF
EZU
$9.41B
| $202K | ﹤0.01% |
4,792
| – | – |
|
|
TELN
1105
DELISTED
TELENOR ASA
TELN
| $200K | ﹤0.01% |
2,935
+33
| +1% | +$2.25K |
|
1106
Dorman Products
DORM
$4.01B
| $199K | ﹤0.01% |
4,051
+142
| +4% | +$7.75K |
|
|
AVP
1107
DELISTED
Avon Products, Inc.
AVP
| $199K | ﹤0.01% |
13,761
-3,629
| -21% | -$52.3K |
|
1108
Capri Holdings
CPRI
$1.77B
| $198K | ﹤0.01% |
2,243
-280
| -11% | -$25.7K |
|
|
XXIA
1109
DELISTED
Ixia
XXIA
| $198K | ﹤0.01% |
+17,383
| New | +$212K |
|
|
JAH
1110
DELISTED
JARDEN CORPORATION
JAH
| $197K | ﹤0.01% |
4,989
-615
| -11% | -$23.4K |
|
1111
KKR & Co
KKR
$89.2B
| $195K | ﹤0.01% |
8,084
-3,716
| -31% | -$86.5K |
|
1112
Knowles
KN
$3.22B
| $195K | ﹤0.01% |
6,367
-32,148
| -83% | -$972K |
|
1113
Sally Beauty Holdings
SBH
$1.4B
| $195K | ﹤0.01% |
7,780
| – | – |
|
1114
Broadridge
BR
$17.2B
| $194K | ﹤0.01% |
4,682
-500
| -10% | -$19.6K |
|
1115
El Paso Energy Capital Trust I
EP.PRC
$225M
| $193K | ﹤0.01% |
3,500
| – | – |
|
1116
Silgan Holdings
SLGN
$4.91B
| $193K | ﹤0.01% |
7,600
| – | – |
|
|
TEF
1117
DELISTED
Telefonica
TEF
| $192K | ﹤0.01% |
15,347
+1,313
| +9% | +$16K |
|
1118
KBR
KBR
$4.68B
| $191K | ﹤0.01% |
8,051
+2,423
| +43% | +$60.8K |
|
1119
iShares S&P 500 Value ETF
IVE
$48.9B
| $190K | ﹤0.01% |
2,112
+84
| +4% | +$7.42K |
|
1120
Equity Residential
EQR
$25.4B
| $189K | ﹤0.01% |
3,000
| – | – |
|
|
IPXL
1121
DELISTED
Impax Laboratories, Inc.
IPXL
| $189K | ﹤0.01% |
6,304
| – | – |
|
1122
Bio-Rad Laboratories Class A
BIO
$8.42B
| $188K | ﹤0.01% |
1,575
| – | – |
|
1123
AptarGroup
ATR
$8.45B
| $187K | ﹤0.01% |
2,799
-136
| -5% | -$9.04K |
|
1124
Barclays
BCS
$94.1B
| $187K | ﹤0.01% |
13,876
+175
| +1% | +$2.65K |
|
1125
State Street SPDR Dow Jones REIT ETF
RWR
$1.93B
| $187K | ﹤0.01% |
2,259
+2,071
| +1,102% | +$169K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q2 2014 Portfolio in Review
As of Q2 2014, Glenmede Trust held 2,523 positions worth $11.1B, up 3.3% from $10.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Glenmede Trust's Q2 2014 filing shows 200 new, 627 increased, 680 reduced and 198 closed positions. Its largest new stake was ARRIS International plc Ordinary Shares: 651,629 shares worth $21.2M. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $33.3M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Industrials and Healthcare.
- Glenmede Trust's largest Q2 2014 buy was ARRIS International plc Ordinary Shares: 651,629 shares worth $21.2M.
- Glenmede Trust added most to Boeing in Q2 2014, an estimated $22.5M increase.
- Glenmede Trust's biggest Q2 2014 reduction was PROTECTIVE LIFE CORP, cutting an estimated $27.2M.
- Glenmede Trust fully exited Vanguard FTSE All-World ex-US ETF in Q2 2014, selling an estimated $33.3M.
- Glenmede Trust's ten largest holdings make up 14% of its $11.1B portfolio in Q2 2014.
- Glenmede Trust opened 200 new positions and closed 198 in Q2 2014.
- Glenmede Trust's portfolio value rose 3.3% quarter-over-quarter to $11.1B.
Based on Glenmede Trust's 13F filing for Q2 2014, filed 13 Aug 2014.